MYL9 antibody (pSer20)
Quick Overview for MYL9 antibody (pSer20) (ABIN872283)
Target
See all MYL9 AntibodiesReactivity
Host
Clonality
Conjugate
Application
- 
    - 
                                            Binding Specificity
- pSer20
- 
                                            Cross-Reactivity
- Human, Rat
- 
                                            Predicted Reactivity
- Mouse,Dog,Cow,Sheep,Pig,Rabbit
- 
                                            Purification
- Purified by Protein A.
- 
                                            Immunogen
- KLH conjugated synthetic phosphopeptide derived from human Myosin Regulatory Light polypeptide 9 around the phosphorylation site of Ser20
- 
                                            Isotype
- IgG
 
- 
                                            
- 
    
- 
    - 
                                            Application Notes
- 
                        WB 1:300-5000
 ELISA 1:500-1000
 IHC-P 1:200-400
 IHC-F 1:100-500
 IF(IHC-P) 1:50-200
 IF(IHC-F) 1:50-200
 IF(ICC) 1:50-200
- 
                                            Restrictions
- For Research Use only
 
- 
                                            
- 
    - 
                                            Format
- Liquid
- 
                                            Concentration
- 1 μg/μL
- 
                                            Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
- 
                                            Preservative
- ProClin
- 
                                            Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
- 
                                            Storage
- 4 °C,-20 °C
- 
                                            Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
- 
                                            Expiry Date
- 12 months
 
- 
                                            
- 
    - 
                                            : "Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway."    in: Chinese journal of integrative medicine, Vol. 20, Issue 3, pp. 216-23, (2014)         (PubMed).        
 : "Cellular contractility changes are sufficient to drive epithelial scattering." in: Experimental cell research, Vol. 326, Issue 2, pp. 187-200, (2014) (PubMed).
 : "Preventive effects of the anti-vasospasm agent via the regulation of the Rho-kinase pathway on the development of steroid-induced osteonecrosis in rabbits." in: Bone, Vol. 53, Issue 2, pp. 329-35, (2013) (PubMed).
 
 
- 
                                            : "Tanshinone II a protects against lipopolysaccharides-induced endothelial cell injury via Rho/Rho kinase pathway."    in: Chinese journal of integrative medicine, Vol. 20, Issue 3, pp. 216-23, (2014)         (PubMed).        
- 
    - MYL9 (Myosin Regulatory Light Polypeptide 9 (MYL9))
- 
                                            Alternative Name
- MYL9
- 
                                            Background
- 
                        Synonyms: LC20, MLC2, MRLC1, MYRL2, MLC-2C, Myosin regulatory light polypeptide 9, 20 kDa myosin light chain, Myosin RLC, Myosin regulatory light chain 2, smooth muscle isoform, Myosin regulatory light chain 9, Myosin regulatory light chain MRLC1, MYL9 Background: Myosin regulatory subunit that plays an important role in regulation of both smooth muscle and nonmuscle cell contractile activity via its phosphorylation. Implicated in cytokinesis, receptor capping, and cell locomotion. 
- 
                                            Gene ID
- 10398
- 
                                            UniProt
- P24844
 Target
- 
                    
 
                                     
                                     
                                    